Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres

AAPS PharmSciTech. 2021 Mar 29;22(3):119. doi: 10.1208/s12249-021-01965-4.

Abstract

Despite the importance of drug release testing of parenteral depot formulations, the current in vitro methods still require ameliorations in biorelevance. We have investigated here the use of muscle tissue components to better mimic the intramuscular administration. For convenient handling, muscle tissue was used in form of a freeze-dried powder, and a reproducible process of incorporation of tested microspheres to an assembly of muscle tissue of standardized dimensions was successfully developed. Microspheres were prepared from various grades of poly(lactic-co-glycolic acid) (PLGA) or ethyl cellulose, entrapping flurbiprofen, lidocaine, or risperidone. The deposition of microspheres in the muscle tissue or addition of only isolated lipids into the medium accelerated the release rate of all model drugs from microspheres prepared from ester-terminated PLGA grades and ethyl cellulose, however, not from the acid-terminated PLGA grades. The addition of lipids into the release medium increased the solubility of all model drugs; nonetheless, also interactions of the lipids with the polymer matrix (ad- and absorption) might be responsible for the faster drug release. As the in vivo drug release from implants is also often faster than in simple buffers in vitro, these findings suggest that interactions with the tissue lipids may play an important role in these still unexplained observations.

Keywords: PLGA; biorelevant,; depot microspheres,; in vitro release,; intramuscular,.

MeSH terms

  • Animals
  • Cellulose / analogs & derivatives
  • Delayed-Action Preparations*
  • Drug Carriers
  • Drug Compounding
  • Drug Liberation
  • Excipients
  • Flurbiprofen / administration & dosage
  • In Vitro Techniques
  • Infusions, Parenteral*
  • Lidocaine / administration & dosage
  • Microspheres
  • Muscles / metabolism*
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Risperidone / administration & dosage
  • Swine

Substances

  • Delayed-Action Preparations
  • Drug Carriers
  • Excipients
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Flurbiprofen
  • ethyl cellulose
  • Cellulose
  • Lidocaine
  • Risperidone